The enhanced atorvastatin hepatotoxicity in diabetic rats was partly attributed to the upregulated hepatic Cyp3a and SLCO1B1

[1]  P. Xu,et al.  Decreased exposure of atorvastatin in diabetic rats partly due to induction of hepatic Cyp3a and Oatp2 , 2016, Xenobiotica; the fate of foreign compounds in biological systems.

[2]  R. Vrzal,et al.  A food contaminant ochratoxin A suppresses pregnane X receptor (PXR)-mediated CYP3A4 induction in primary cultures of human hepatocytes. , 2015, Toxicology.

[3]  Daidi Fan,et al.  Effect of Stay-Green Wheat, a Novel Variety of Wheat in China, on Glucose and Lipid Metabolism in High-Fat Diet Induced Type 2 Diabetic Rats , 2015, Nutrients.

[4]  Xiao-dong Liu,et al.  Decreased exposure of simvastatin and simvastatin acid in a rat model of type 2 diabetes , 2014, Acta Pharmacologica Sinica.

[5]  Y. Turkoz,et al.  Cytoprotective effects of amifostine, ascorbic acid and N-acetylcysteine against methotrexate-induced hepatotoxicity in rats. , 2014, World journal of gastroenterology.

[6]  E. Plise,et al.  Differential Effects of Rifampin and Ketoconazole on the Blood and Liver Concentration of Atorvastatin in Wild-Type and Cyp3a and Oatp1a/b Knockout Mice , 2014, Drug Metabolism and Disposition.

[7]  Xiao-dong Liu,et al.  Co-administration of paroxetine and pravastatin causes deregulation of glucose homeostasis in diabetic rats via enhanced paroxetine exposure , 2014, Acta Pharmacologica Sinica.

[8]  Xiao-dong Liu,et al.  Increased levels of fatty acids contributed to induction of hepatic CYP3A4 activity induced by diabetes - in vitro evidence from HepG2 cell and Fa2N-4 cell lines. , 2014, Journal of pharmacological sciences.

[9]  Xiao-dong Liu,et al.  Increased glucagon-like peptide-1 secretion may be involved in antidiabetic effects of ginsenosides. , 2013, The Journal of endocrinology.

[10]  Kazuya Maeda,et al.  Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption. , 2013, Biopharmaceutics & drug disposition.

[11]  N. Chandel,et al.  Physiological roles of mitochondrial reactive oxygen species. , 2012, Molecular cell.

[12]  I. Tamai.  Oral drug delivery utilizing intestinal OATP transporters. , 2012, Advanced drug delivery reviews.

[13]  Evangelos Kalaitzakis,et al.  Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing. , 2012, Journal of hepatology.

[14]  S. Krähenbühl,et al.  Susceptibility to simvastatin-induced toxicity is partly determined by mitochondrial respiration and phosphorylation state of Akt. , 2011, Biochimica et biophysica acta.

[15]  S. Nesnow,et al.  Propiconazole increases reactive oxygen species levels in mouse hepatic cells in culture and in mouse liver by a cytochrome P450 enzyme mediated process. , 2011, Chemico-biological interactions.

[16]  A. Holbrook,et al.  Statin-associated rhabdomyolysis: is there a dose-response relationship? , 2011, The Canadian journal of cardiology.

[17]  S. Krähenbühl,et al.  The role of CYP3A4 in amiodarone-associated toxicity on HepG2 cells. , 2011, Biochemical pharmacology.

[18]  Katrin Wlcek,et al.  Organic anion transporting polypeptides (OATPs): regulation of expression and function. , 2011, Current drug metabolism.

[19]  H. Elewa,et al.  Early Atorvastatin Reduces Hemorrhage after Acute Cerebral Ischemia in Diabetic Rats , 2009, Journal of Pharmacology and Experimental Therapeutics.

[20]  B. Moosmann,et al.  Statin-Induced Liver Injury Involves Cross-Talk between Cholesterol and Selenoprotein Biosynthetic Pathways , 2009, Molecular Pharmacology.

[21]  Guoliang Zhang,et al.  Clozapine-induced hepatotoxicity in rat hepatocytes by gel entrapment and monolayer culture. , 2008, Toxicology in vitro : an international journal published in association with BIBRA.

[22]  J. Kimura,et al.  Involvement of organic anion transporting polypeptides in the toxicity of hydrophilic pravastatin and lipophilic fluvastatin in rat skeletal myofibres , 2008, British journal of pharmacology.

[23]  Chao-Yung Wang,et al.  Pleiotropic effects of statin therapy: molecular mechanisms and clinical results. , 2008, Trends in molecular medicine.

[24]  K. Jeyaseelan,et al.  Reduced mitochondrial coenzyme Q10 levels in HepG2 cells treated with high-dose simvastatin: a possible role in statin-induced hepatotoxicity? , 2007, Toxicology and Applied Pharmacology.

[25]  U. Laufs,et al.  Anti-inflammatory effects of atorvastatin improve left ventricular function in experimental diabetic cardiomyopathy , 2007, Diabetologia.

[26]  J. Duarte,et al.  Single high dose dexamethasone treatment decreases the pathological score and increases the survival rate of paraquat-intoxicated rats. , 2006, Toxicology.

[27]  H. Bays.  Statin safety: an overview and assessment of the data--2005. , 2006, The American journal of cardiology.

[28]  Stefan O Mueller,et al.  Effects of cell culture conditions on primary rat hepatocytes-cell morphology and differential gene expression. , 2006, Toxicology.

[29]  K. Brouwer,et al.  Viability assessment in sandwich-cultured rat hepatocytes after xenobiotic exposure. , 2004, Toxicology in vitro : an international journal published in association with BIBRA.

[30]  S. Toyokuni,et al.  CYP3A induction aggravates endotoxemic liver injury via reactive oxygen species in male rats. , 2004, Free radical biology & medicine.

[31]  John H Fuller,et al.  Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial , 2004, The Lancet.

[32]  S. Grundy,et al.  ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins. , 2002, Circulation.

[33]  Claude Lenfant,et al.  ACC/AHA/NHLBI clinical advisory on the use and safety of statins. , 2002, Journal of the American College of Cardiology.

[34]  N. Hagenbuch,et al.  Effect of phenobarbital on the expression of bile salt and organic anion transporters of rat liver. , 2001, Journal of hepatology.

[35]  B. Roth,et al.  Metabolism and excretion of atorvastatin in rats and dogs. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[36]  P. Neuvonen,et al.  Effect of itraconazole on the pharmacokinetics of atorvastatin , 1998, Clinical pharmacology and therapeutics.

[37]  N. Shimojo.  Cytochrome P450 changes in rats with streptozocin-induced diabetes. , 1994, The International journal of biochemistry.

[38]  S. Imaoka,et al.  Changes in amounts of cytochrome P450 isozymes and levels of catalytic activities in hepatic and renal microsomes of rats with streptozocin-induced diabetes. , 1993, Biochemical pharmacology.

[39]  M. Sari,et al.  Oxidation of dihydropyridine calcium channel blockers and analogues by human liver cytochrome P-450 IIIA4. , 1991, Journal of medicinal chemistry.

[40]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[41]  M. J. Coon,et al.  Oxygen activation by cytochrome P-450. , 1980, Annual review of biochemistry.